These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5903181)

  • 1. Enzyme-alterable alkylating agents. IX. The enzymatic transformation of some nitrogen mustards in the presence of carbon dioxide: implications in respiration.
    Williamson CE; Kirby JG; Miller JI; Sass S; Kramer SP; Seligman AM; Witten B
    Cancer Res; 1966 Feb; 26(2):323-30. PubMed ID: 5903181
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the methodology of the determination of alkylating activities of nitrogen mustards with nitrobenzylpyridine (NBP) in biological material (author's transl)].
    Hesse G; Schulze W; Wachtel E
    Pharmazie; 1981 Sep; 36(9):609-12. PubMed ID: 7301901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative evaluation of the blood-depressing action of alkylating agents].
    Kireeva IV; Khomchenovskiĭ EI; Pykhtina AA
    Farmakol Toksikol; 1982; 45(5):90-3. PubMed ID: 7140963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the chemical structure on the biological tendency of cytostatic compounds related to dibromomanitol. II. Mechanism of action.
    Horváth IP; Institóris L
    Arzneimittelforschung; 1967 Feb; 17(2):149-55. PubMed ID: 5631482
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
    Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
    Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship of labeled molecules in the pharmacokinetic study of alkylating agents (chlorambucil, melphalan, mitoclomine) and glycosyl nitrosoureas (RFCNU and RPCNU)].
    Meyniel G; Godenech D
    Nouv Rev Fr Hematol (1978); 1979; Suppl():XXXIII-XXXV. PubMed ID: 545309
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of macromolecules as carriers of cytotoxic groups (part I) conjugates of nitrogen mustards with proteins, polypeptidyl proteins and polypeptides.
    Szekerke M; Wade R; Whisson ME
    Neoplasma; 1972; 19(3):199-209. PubMed ID: 5065390
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunodepressant activity of certain radiomimetics in immunization of mice with sheep erythrocytes].
    Kazarian KA
    Biull Eksp Biol Med; 1970 Mar; 69(3):87-91. PubMed ID: 4994633
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemical mutagenesis].
    Sobels FH
    Pharm Weekbl; 1972 Jun; 107(24):365-74. PubMed ID: 5036742
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular pharmacokinetics of the phenylalanine mustards.
    Vistica DT
    Pharmacol Ther; 1983; 22(3):379-406. PubMed ID: 6361804
    [No Abstract]   [Full Text] [Related]  

  • 11. [A volatile alkylating agent in the exhaled air following the administration of Endoxan].
    Rauen HM; Norpoth K
    Klin Wochenschr; 1968 Mar; 46(5):272-5. PubMed ID: 5697858
    [No Abstract]   [Full Text] [Related]  

  • 12. THE DURATION OF THE MYELOTOXIC EFFECTS OF CIRCULATING ALKYLATING AGENTS.
    ULFOHN A; KRAMER SP; DORFMAN H; WITTEN B; WILLIAMSON C; SASS S; MILLER JI; SELIGMAN AM
    Cancer Res; 1964 Oct; 24():1659-65. PubMed ID: 14234010
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of inactivation of DNA and RNA bacteriophages by alkylating agents in vitro.
    Yamamoto N; Naito T; Shimkin MB
    Cancer Res; 1966 Nov; 26(11):2301-6. PubMed ID: 5956634
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme-alterable alkylating agents. III. Synthesis, chemical properties, and toxicities of mustards containing enzyme-susceptible ester bonds.
    WITTEN B; SASS S; MILLER JI; WILLIAMSON CE; GUERRERO HG; KRAMER SP; SOLOMON RD; GOODMAN LE; SELIGMAN AM
    Cancer; 1962; 15():1062-72. PubMed ID: 14007766
    [No Abstract]   [Full Text] [Related]  

  • 15. The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs.
    Vogel CL; Denham C; Waalkes TP; DeVita VT
    Cancer Res; 1970 Jun; 30(6):1651-7. PubMed ID: 5457935
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular mechanism of the toxic action of alkylating agents].
    Verly WG; Brakier L
    Rev Eur Etud Clin Biol; 1970 May; 15(5):483-8. PubMed ID: 5430154
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme-alterable alkylating agents. I. Synthesis, chemical properties, and toxicities of sulfur mustards containing enzyme-susceptible amide bonds.
    WITTEN B
    Cancer; 1962; 15():1041-55. PubMed ID: 14007768
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaco-biochemical studies on cytotoxic polyol derivatives. II. The effect of biological alkylating agents on the thermal-denaturation properties of DNA.
    Jeney A; Szabó I; Vályi-Nagy T; Szabó J; Institoris L
    Eur J Cancer (1965); 1970 Aug; 6(4):297-302. PubMed ID: 5485266
    [No Abstract]   [Full Text] [Related]  

  • 19. STUDIES OF THE MODE OF ACTION OF TUMOUR-GROWTH-INHIBITING ALKYLATING AGENTS. V. THE METABOLISM OF 2-CHLOROETHYLARYLAMINES.
    ROBERTS JJ; WARWICK GP
    Biochem Pharmacol; 1963 Dec; 12():1321-8. PubMed ID: 14096419
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
    Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
    J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.